NooLVL (Inositol-enhanced Bonded Arginine Silicate)

NooLVL is a patented cognitive enhancement compound combining inositol-stabilized arginine silicate that enhances nitric oxide production in the brain. This nootropic ingredient improves executive function, processing speed, and reaction time through increased cerebral blood flow and neurotransmitter optimization.

Category: Other Evidence: 2/10 Tier: Moderate (some RCTs)
NooLVL (Inositol-enhanced Bonded Arginine Silicate) — Hermetica Encyclopedia

Origin & History

NooLVL is a branded nutritional supplement consisting of inositol-enhanced bonded arginine silicate (IEBAS), developed by Nutrition 21 (Purchase, NY, USA) specifically for cognitive enhancement in eSports gamers. The ingredient combines arginine silicate with inositol in a stabilized form, though no specific source organism or traditional extraction method is detailed in available studies.

Historical & Cultural Context

No evidence of historical or traditional medicinal use exists for NooLVL. This is a modern branded ingredient developed specifically for nootropic applications in eSports, with no pre-clinical traditional context noted in available research.

Health Benefits

• Improved executive function including processing speed and task switching (demonstrated in RCT with 61 gamers, PMID: 31581523) • Reduced cognitive errors during gaming tasks as measured by Stroop Test performance (moderate evidence from controlled trials) • Enhanced reaction time and sustained attention shown in Sternberg Mean Present Reaction Time tests (PMID: 34836014) • Increased vigor and decreased anger during gaming sessions (reported in 7-day supplementation trial) • Faster completion of Trail Making Test A indicating improved visual attention and processing speed (p<0.05 vs placebo)

How It Works

NooLVL increases nitric oxide synthase activity, promoting vasodilation and enhanced cerebral blood flow through arginine's conversion to nitric oxide. The inositol component stabilizes cellular membranes and supports neurotransmitter signaling pathways including acetylcholine and dopamine. The silicate matrix enhances bioavailability and sustained release of active compounds.

Scientific Research

Clinical evidence comes from randomized, double-blind, placebo-controlled trials in eSports gamers, including a 7-day parallel-group study (n=61, PMID: 31581523) and a crossover trial examining acute cognitive effects (PMID: 34836014). Related research on arginine silicate showed effect sizes of d=0.45-0.80 for executive function improvements (PMID: 27869715).

Clinical Summary

A randomized controlled trial with 61 gamers demonstrated significant improvements in executive function and processing speed after NooLVL supplementation (PMID: 31581523). Participants showed reduced cognitive errors on Stroop Test performance and enhanced task-switching abilities compared to placebo. The study used standard gaming performance metrics and neuropsychological assessments, providing moderate-quality evidence for cognitive benefits. Additional controlled trials have confirmed improvements in reaction time and sustained attention during complex cognitive tasks.

Nutritional Profile

NooLVL is a specialized compound consisting of bonded arginine silicate complexed with inositol, standardized to deliver approximately 1,500 mg of inositol-enhanced bonded arginine silicate per serving (as used in clinical trials). Macronutrient contribution is negligible — essentially zero fat, zero fiber, and minimal caloric load (<5 kcal per typical dose). Key bioactive components include: (1) L-Arginine: present as the primary amino acid constituent within the silicate complex, estimated at approximately 750–900 mg per 1,500 mg dose; serves as a precursor to nitric oxide (NO) via nitric oxide synthase (NOS) pathways, supporting cerebrovascular blood flow. (2) Silicon (as arginine silicate): silicon is a trace mineral component of the bonded complex; the silicate matrix is proposed to enhance arginine stability and bioavailability compared to free-form L-arginine, reducing first-pass hepatic metabolism and improving sustained plasma arginine levels. (3) Inositol (myo-inositol): standardized at approximately 100 mg per 1,500 mg dose of NooLVL; functions as a secondary messenger precursor involved in phosphatidylinositol signaling pathways, insulin signal transduction, and neurotransmitter receptor sensitivity. Bioavailability notes: The bonded silicate matrix significantly improves arginine bioavailability versus equivalent doses of free L-arginine; inositol inclusion is hypothesized to potentiate NO-mediated cerebrovascular effects synergistically. No significant vitamin or dietary fiber content is present in this ingredient as a standalone compound.

Preparation & Dosage

Clinically studied dose is 1 stick pack daily in powder form, taken acutely 30 minutes before gaming or daily for 7 days. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-theanine, caffeine, alpha-GPC, rhodiola rosea, bacopa monnieri

Safety & Interactions

NooLVL is generally well-tolerated with minimal reported side effects in clinical trials. Potential interactions may occur with blood pressure medications due to nitric oxide enhancement effects on vasodilation. Individuals with cardiovascular conditions should consult healthcare providers before use, as arginine compounds can affect blood pressure regulation. Safety during pregnancy and breastfeeding has not been established through clinical research.